Vorinostat, an HDAC inhibitor, alters gene expression and has been used in the treatment of various cancers and autoimmune diseases.[49,50] Given their roles in modulating immune and inflammatory pathways, we selected these 2 compounds for further analysis to explore their therapeutic potential in SLE. This evidence concerns the gene HDAC9 and cancer.